GIP Receptor Antagonists in the Pharmacotherapy of Obesity: Physiologic, Genetic, and Clinical Rationale. Rosenkilde MM, George JT, Veniant MM, Holst JJ, et al. Diabetes 2025 Jun 16:dbi240027. doi: 10.2337/dbi24-0027.

Read + Share

Amedeo Smart

Independent Medical Education

Rosenkilde MM, George JT, Veniant MM, Holst JJ, et al. GIP Receptor Antagonists in the Pharmacotherapy of Obesity: Physiologic, Genetic, and Clinical Rationale. Diabetes 2025 Jun 16:dbi240027. doi: 10.2337/dbi24-0027.
PMID: 40521869